Results 91 to 100 of about 3,282 (196)
Evaluating the Effects of Testing Period on Pollinosis Symptoms Using an Allergen Challenge Chamber
BackgroundWe previously built a pollen challenge test unit (allergen challenge chamber: ACC) to collect objective data about Japanese cedar pollinosis. In this study, we investigated adequate conditions for pollen challenge using the ACC.MethodsThe study
Tetsuya Terada +6 more
core +1 more source
application/pdfMethods:Subjects were 382 young adult volunteers who completed a self-administered questionnaire on self-reported subjective symptoms of pollinosis, physician-diagnosed pollinosis, and background factors.
Nakamura, Satoshi +2 more
core
Patterns of Drug Prescription for Japanese Cedar Pollinosis Using a Clinical Vignette Questionnaire
BackgroundAlthough prescribed drugs directly affect patient outcome, the variation in physicians' attitudes towards drug therapy for cedar pollinosis has not been quantitatively assessed.
Takeo Nakayama +3 more
core +1 more source
The aim: the analysis of spectrum of causatively relevant aeroallergens of southern Ukraine which provoke allergic reaction in patients with pollinosis.
Myrhorod, A. V. +2 more
core
Not available.
Gutiérrez-Bustillo, Montserrat +3 more
openaire +1 more source
Successful Omalizumab Treatment of Rhinogenic Contact Point Headache Complicated by Severe Cedar Pollinosis: A Case Report. [PDF]
Suzaki I +4 more
europepmc +1 more source
Effects of olopatadine hydrochloride on substance P concentrations in nasal secretions and nasal symptoms. [PDF]
Katagiri F +5 more
europepmc +1 more source
Trends in the prevalence of childhood allergic diseases in Japan: Comparison of surveys conducted in 1982, 1992, 2002, 2012, and 2022 (WJSAAC phase I-V). [PDF]
Nishima S +3 more
europepmc +1 more source
Cedar pollinosis is a significant public health issue in Japan, with a prevalence reaching 38.8 % in 2019. This study evaluates college students’ willingness-to-pay (WTP) for artificial cedar forest reforestation in Oita Prefecture to reduce the adverse ...
Koichi Yamaura, Kenta Tomizuka
core +1 more source
Lebrikizumab for atopic dermatitis in the elderly: A case series. [PDF]
Gruber B.
europepmc +1 more source

